Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice

Synapse

Volumn 62, Issue 1, 2008, Pages 8-13

  Yoo, Ji Hoon ^a,b   Nam, Yun Sun ^a   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

5 HT3; Autoradiography; Dopamine; Dopamine transporters; Methamphetamine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BEMESETRON; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; MAZINDOL; METHAMPHETAMINE; RACLOPRIDE; SEROTONIN; SEROTONIN 3 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG MECHANISM; HYPERACTIVITY; ISOTOPE LABELING; LIGAND BINDING; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SEROTONIN BRAIN LEVEL; STATISTICAL ANALYSIS;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; TROPANES;

EID: 36348990216     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20461     Document Type: Article

References (25)

1. 3H]spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity. Biol Psychiatry 17:223-231.
2. Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. 2006. The need for speed: An update on methamphetamine addiction. J Psychiatry Neurosci 31:301-313.
3. Blandina P, Goldfarb J, Craddock-Royal B, Green JP. 1989. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. J Pharmacol Exp Ther 251:803-809.
4. Bustamante D, You Z-B, Castel M-N, Johansson S, Goiny M, Terenius L, Hokfelt T, Herrera-Marschitz M. 2002. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem 83:645-654.
5. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543:354-357.
6. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92:881-894.
7. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR. 1997a. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838.
8. Fleckenstein AE, Wilkins DG, Gibb JW, Hanson GR. 1997b. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther 283:281-285.
9. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. 2007. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681-698.
10. 3 receptors in drug dependence. Drug Alcohol Depend 38:155-171.
11. Kitanaka N, Kitanaka J, Takemura M. 2003. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 474:63-70.
12. 3 receptor in the pressure-induced increase in striatal and accumbens dopamine release and the occurrence of behavioral disorders in free-moving rats. Neurosci Lett 197:57-60.
13. 2 receptor binding in the rat brain and pituitary: An in situ hybridization- receptor autoradiographic analysis. J Neurosci 10:2587-2600.
14. 2 dopamine receptors as evidenced by autoradiography: Comparison with tyrosine hydroxylase activity. Neuroscience 23:253-261.
15. McKetin R, McLaren J, Lubman DI, Hides L. 2006. The prevalence of psychotic symptoms among methamphetamine users. Addiction 101:1473-1478.
16. 1-dopamine receptor ligand, in the rat brain. Neurosci Lett 120:109-112.
17. 2 receptors in the forebrain of dystonia musculorum mutant mice: An autoradiographic survey in relation to dopamine contents. Synapse 37:1-15.
18. 1 dopamine receptor neurons. Neuroscience 95:1025-1033.
19. Porras G, De Deurwaerdere P, Moison D, Spampinato U. 2003. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. Eur J Neurosci 17:771-781.
20. Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M. 2003. Psychotic symptoms in methamphetamine psychotic inpatients. Int J Neuropsychopharmacol 6:347-352.
21. Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR. 1999. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371:123-135.
22. Ujike H, Sato M. 2004. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann NY Acad Sci 1025:279-287.
23. 2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 98:89-92.
24. Woo S-H, Kim H-S, Yun J-S, Lee M-K, Oh K-W, Seong Y-H, Oh S-K, Jang C-G. 2001. Inhibition of Baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity. Pharmacol Res 43:335-340.
25. 3A receptor channel and binding study. J Neurochem 99:976-988.